United States · FDA National Drug Code directory
Indium In 111 Oxyquinoline
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72536-0920_0864f662-e3ce-4426-8c3c-e318f755a89d
- Product NDC
- 72536-0920
- Form
- LIQUID
- Composition / generic term
- Indium In-111 Oxyquinoline
- Labeler
- BWXT Medical Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190927
- Source listing expiry
- 20261231
Source-listed ingredients
- INDIUM IN-111 OXYQUINOLINE — 1 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 mL in 1 VIAL, SINGLE-DOSE (72536-0920-1) · 72536-0920-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →